These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36149152)

  • 1. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
    Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
    J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
    Torres-Rendon A; Roy S; Craig GT; Speight PM
    Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA replication licensing factor MCM2, geminin, and Ki67 define proliferative state and are linked with survival in oral squamous cell carcinoma.
    Al-Hazmi N; Alhazzazi T; Williams G; Stoeber K; Al-Dabbagh R
    Eur J Oral Sci; 2018 Jun; 126(3):186-196. PubMed ID: 29745471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
    Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
    Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
    Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
    Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
    Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck.
    Alaeddini M; Etemad-Moghadam S
    Braz J Otorhinolaryngol; 2022; 88(4):529-532. PubMed ID: 32972865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma.
    Birajdar SS; Radhika M; Paremala K; Sudhakara M; Soumya M; Gadivan M
    J Oral Maxillofac Pathol; 2014 May; 18(2):169-76. PubMed ID: 25328294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
    Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
    J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cellular proliferation in oral verrucous carcinoma and well-differentiated oral squamous cell carcinoma using Ki67: a non-reliable factor for differential diagnosis?
    Zargaran M; Eshghyar N; Baghaei F; Moghimbeigi A
    Asian Pac J Cancer Prev; 2012; 13(11):5811-5. PubMed ID: 23317261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
    Juneja S; Chaitanya NB; Agarwal M
    Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
    Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
    Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions.
    Dash KC; Mahapatra N; Bhuyan L; Panda A; Behura SS; Mishra P
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S274-S278. PubMed ID: 33149470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
    Shen Y; Xu Z; Liu M; Piao S; Li J
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive expression of DNA replication factors in squamous cell carcinomas of the lip, face and oral cavity.
    Etemad-Moghadam S; Mohammadpour H; Alaeddini M
    J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e828-e832. PubMed ID: 35217222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transmembrane protein aquaporin-3 in oral epithelial dysplasia and oral squamous cell carcinoma.
    Lekshmy MS; Sivakumar TT; Joseph AP; Varun BR; Mony V; Reshmi A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):202-208. PubMed ID: 33187942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological evaluation of minor salivary gland aberrations in oral squamous cell carcinoma.
    Bhola R; Narwal A; Kamboj M; Devi A; Anand R; Chatterjee S
    J Cancer Res Ther; 2023; 19(2):299-303. PubMed ID: 37313908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.